Updated: RPS could scrap two senior roles in executive team restructure

The Royal Pharmaceutical Society (RPS) could potentially make two senior roles within its executive board redundant as part of a strategy to strengthen the organisation’s “viability”, it has confirmed.

RPS HQ
RPS: “No final decisions or outcomes” have been reached yet

The RPS is “working on a proposal” that could see a restructure at executive level, with “two roles... at potential risk of redundancy”, it said in a statement published this afternoon (March 3).

It could not confirm the two roles “that are at risk”, it told C+D.

The plans are only at proposal stage and “no final decisions or outcomes” have been reached yet, the RPS said.

It could not “go into the specifics of the process...due to its confidential nature” but “a fair, reasonable and confidential consultation process” will be adhered to, it said.

The proposal follows the launch of the RPS Strategy last year, which set out to “further strengthen the viability and sustainability of the organisation”, the RPS added.

“I deeply regret seeing so much speculation”

In an update published on March 4, RPS president Professor Claire Anderson said: “I deeply regret seeing so much speculation in the public domain about a proposed change to the executive team when no decision has yet been made and feel for those involved.”

The proposal “is not about cost savings” but it is an organisational decision on operational matters, she added.

The RPS is “completely committed” to maintaining its work on education, including post-registration curricula, assessment and credentialing, workforce planning, leadership development and mentoring, Professor Anderson said.

“Should the proposal go ahead, there would still be a leader on the executive with responsibility for delivering on our education strategy,” she clarified.

To “protect the confidentiality of the process” and “to be fair to the individuals involved”, an update will only be issued once a decision has been agreed, Professor Anderson concluded.

This story was updated on March 4 to include Professor Anderson's comments

Sign in or register for free

Latest from News

Contractors to receive April and May SAF uplift ‘sooner’

 
• By 
 • comment0

Contractors will reap the benefits of the increased single activity fee (SAF) without having to wait 60 days from the end of April and May, Community Pharmacy England (CPE) has announced.

What pressures do new independent prescribers face?

 
• By 
 • comment2

As all newly qualified pharmacists become independent prescribers from 2026, a pharmacy lecturer shares some of the concerns her students have shared as they complete their studies…

Pfizer scraps second attempt at weight loss pill

 
• By 
 • comment0

Pfizer has announced it will “discontinue” the development of a weight loss pill amid “potential drug-induced liver injury”, less than two years after it decided “not [to] advance” a previous version.

More from Business

Pharmacy assistant murdered by man with a ‘grudge against pharmacies’

 
• By 
 • comment

A pharmacy worker and father-of-two was shot and killed at his workplace by a man who expressed his “disdain” with large-scale pharmacies, US police have revealed.

breaking news

IN FULL: Number of pharmacies drops below 10,000 in 20-year first

 
• By 
 • comment

Only 9,999 bricks-and-mortar pharmacies remained in England at the end of March, NHS Business Services Authority (NHSBSA) data has revealed.